Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.

C1q nephropathy is a rare kidney disease that can present with nephrotic syndrome and typically has the histologic phenotype of either minimal change disease or focal segmental glomerulosclerosis (FSGS). Disagreement exists about whether it is a distinct immune complex-mediated glomerulopathy or it resides in the spectrum of FSGS-minimal change disease. Two African American patients with C1q nephropathy histologically presenting as the collapsing variant of FSGS (collapsing C1q nephropathy) and rapid loss of kidney function were genotyped for polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9). Both cases were homozygous for the MYH9 E1 risk haplotype, the variant strongly associated with idiopathic FSGS, collapsing FSGS in human immunodeficiency virus-associated nephropathy, and focal global glomerulosclerosis (historically attributed to hypertensive nephrosclerosis). Collapsing C1q nephropathy with rapid progression to end-stage renal disease appears to reside in the MYH9-associated disease spectrum.

[1]  C. Winkler,et al.  Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Thomas Meitinger,et al.  Genome-wide linkage analysis of serum creatinine in three isolated European populations. , 2009, Kidney international.

[3]  A. Balduini,et al.  Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation , 2009, Thrombosis and Haemostasis.

[4]  Yongmei Liu,et al.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. , 2009, Kidney international.

[5]  D. Reich,et al.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.

[6]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[7]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[8]  V. D’Agati,et al.  C1q nephropathy: a variant of focal segmental glomerulosclerosis. , 2003, Kidney international.

[9]  V. D’Agati,et al.  Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. , 1996, Kidney international.

[10]  Corinne Antignac,et al.  Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. , 2002, Journal of the American Society of Nephrology : JASN.

[11]  S. Iskandar,et al.  C1q nephropathy: a pediatric clinicopathologic study. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  J. Jennette,et al.  C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.